Mapping the Molecular Profile IMU-935 for the Treatment of Autoimmune Diseases

Time: 9:30 am
day: Day One

Details:

  • Identification of the unique molecular profile of the RORgT inverse agonist IMU-935
  • Choosing the right animal models to demonstrate RORgt impact on disease outcome

Speakers: